Detalhe da pesquisa
1.
Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 403(10423): 249-260, 2024 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048786
2.
Germline assessment for alloHSCT candidates over 50 years: A 'Fast-Track' screening in myeloid neoplasms.
Br J Haematol
; 2024 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38639421
3.
DNA methylation profiling of myelodysplastic syndromes and clinical response to azacitidine: A multicentre retrospective study.
Br J Haematol
; 204(5): 1838-1843, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38471524
4.
Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification.
Br J Haematol
; 204(4): 1529-1535, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38411250
5.
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial.
Lancet
; 402(10399): 373-385, 2023 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37311468
6.
Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study.
Blood
; 140(14): 1635-1649, 2022 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35344580
7.
Sustained response off-treatment in eltrombopag-treated adult patients with ITP who are refractory or relapsed after first-line steroids: Primary, final, and ad-hoc analyses of the Phase II TAPER trial.
Am J Hematol
; 99(1): 57-67, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38014779
8.
Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study.
Blood
; 138(16): 1429-1440, 2021 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34157093
9.
Kinetics of cellular and humoral immunogenicity and effectiveness of SARS-CoV-2 booster vaccination in hematologic neoplasms.
Am J Hematol
; 98(8): 1204-1213, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37151135
10.
Real-world data with the use of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura: A single-center with homogeneous treatment experience.
Transfusion
; 62(11): 2363-2369, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36151933
11.
A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients.
Blood Cells Mol Dis
; 86: 102505, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32979651
12.
Ex vivo T-cell depletion vs post-transplant cyclophosphamide, sirolimus, and mycophenolate mofetil as graft-vs-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation.
Eur J Haematol
; 106(1): 114-125, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33025625
13.
Elucidating the Mechanism of Action of the Attributed Immunomodulatory Role of Eltrombopag in Primary Immune Thrombocytopenia: An In Silico Approach.
Int J Mol Sci
; 22(13)2021 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34199099
14.
Prospective Randomized Study Comparing Myeloablative Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Stem Cell Transplantation for Adults with Hematologic Malignancies.
Biol Blood Marrow Transplant
; 26(2): 358-366, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31655119
15.
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes.
Biol Blood Marrow Transplant
; 26(11): 2139-2146, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32781289
16.
Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia.
Br J Haematol
; 188(5): 605-622, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31621063
17.
Effect of Sirolimus Exposure on the Need for Preemptive Antiviral Therapy for Cytomeglovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(5): 1022-1030, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30639821
18.
Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation: Experience of the Spanish Group of Hematopoietic Stem Cell Transplant.
Biol Blood Marrow Transplant
; 25(9): 1825-1831, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31152794
19.
Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group.
Br J Haematol
; 184(5): 797-807, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30548583
20.
Chronic graft-versus-host disease could ameliorate the impact of adverse somatic mutations in patients with myelodysplastic syndromes and hematopoietic stem cell transplantation.
Ann Hematol
; 98(9): 2151-2162, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31312927